Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

3.19
Delayed Data
As of 4:00pm ET
 -0.05 / -1.54%
Today’s Change
2.83
Today|||52-Week Range
10.10
-55.45%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close3.24
Today’s open3.24
Day’s range3.17 - 3.29
Volume288,417
Average volume (3 months)737,365
Market cap$133.1M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...+0.27+3.16%
NERVMinerva Neuroscience...0.000.00%
IMDZImmune Design Corp0.000.00%
URGNUrogen Pharma Ltd+0.75+1.86%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateJanuary 8, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
EVP, Chief Executive &
Business Officer
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts